Login with ORCID

assertion

Full identifier: http://purl.org/np/RALPXgYIeeBJz_VmALtEz6pNV62tcDqOjDQ2rvCJWlIKE#assertion

Minted in Nanopublication

 RALPXgYIee comment approve/disapprove edit as derived nanopublication

This is a local identifier minted within the nanopublication. http://purl.org/np/RALPXgYIee...#sig
sig
http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RALPXgYIee... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RALPXgYIee...#sig
sig
http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal)
.

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
Elif Ozkan
2022-10-13T12:59:38.148Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
2022-10-13T12:59:38.148390
Elif Ozkan
2022-10-13T12:59:38.148Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
Quinapril in combination with hydrochlorothiazide is indicated for the treatment of hypertension and as an adjunct therapy in the. treatment of heart failure. The drug is also indicated for heart failure and hypertension in addition to heart failure treatment. The study was published in the US National Institute of Medicine (NICE) and published in Europe and Asia, Europe, Australia, Australia and Japan respectively.
Elif Ozkan
2022-10-13T12:59:38.148Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)